Life science giant Thermo Fisher acquires stem cell MTI-GlobalStem

On November 29th, Thermo Fisher Scientific, a global leader in scientific services, announced that it has signed an agreement to acquire stem cell product company MTI-GlobalStem, but the financial terms and other terms of the transaction. None of them were announced, but the company said that after the transaction is completed, MTI-GlobalStem will be integrated into Thermo Scientific's Life Sciences Solutions division.

It is reported that MTI-GlobalStem was founded in 2006, originally named GlobalStem, was acquired by Molecular Transfer (MTI) in 2010, and is headquartered in Gaithersburg, Maryland, USA, dedicated to the development and promotion of cell transfection, neurobiology. And tools and reagents for stem cell research. In addition, the company offers stem cells, differentiated neurons and large-scale cell culture manufacturing services.

Acquired a stem cell company MTI-GlobalStem

Scientists at the MTI team are also not idle, and they have been involved in the development of several well-known products in the fields of transfection, transformation, nucleic acid technology and gene expression. According to reports, these scientists led the development of the famous transfection reagent Lipofectamine during his tenure at BRL/Life Technologies. They also collaborated with Professor Doug Hanahan of the University of California, San Francisco to develop and promote the well-known DH5α and DH10B? series.

Today, MTI-GlobalStem develops a range of strength products with expertise in transfection, neurobiology and stem cell biology. They have introduced primary and iPSC-derived nerve cells, stem cells and trophoblast cells, and have developed novel transfection reagents that can efficiently introduce nucleic acids into stem cells and neurons. MTI-GlobalStem has also introduced a series of introduction reagents for the current hot CRISPR gene editing.

Amy Butler, vice president of cell biology at Thermo Fisher, said: "The addition of MTI-GlobalStem technology will further strengthen Thermo Fisher's leading position in the biosciences and provide more advanced research products to scientists around the world. Their technology and expertise, as well as Thermo Fisher's global business position, is a strategic fit that will allow us to better serve our customers in transfection and stem cell research."

Non-medical KN95 Face Mask

Kn95 Cup 3D Mask,Kn95 Protective Mask,Kn95 Face Mask Online,Non-Medical Kn95 Face Mask

Jiangmen anjian biotechnology co. LTD , https://www.jmanjianmask.com